Clinical trial
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety…
NCT00074802 · Temple University, Other · Completed
Key facts
| NCT number | NCT00074802 |
|---|---|
| Title | Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder |
| Official title | CBT Augmentation of Paroxetine for Social Anxiety |
| Lead sponsor | Temple University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Paroxetine, Cognitive behavioral therapy (CBT) |
| Enrollment | 150 |
| Start date | Dec 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 22, 2003 |
| Last update posted | Jun 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: